CSIMarket
 


Nexgel Inc   (NXGL)
Other Ticker:  
 
 

NXGL's Revenue Growth by Quarter and Year

Nexgel Inc 's Revenue results by quarter and year




NXGL Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.52 0.00 0.00
III Quarter September - 0.57 0.00 0.00
II Quarter June 1.17 0.56 0.00 0.00
I Quarter March 0.62 0.40 0.00 0.00
FY   1.79 2.05 0.00 0.00



NXGL Revenue second quarter 2023 Y/Y Growth Comment
Nexgel Inc achieved in the second quarter 2023, above Company average Revenue surge of 108.39% year on year, to $ 1.17 millions.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 9 other companies have achieved higher Revenue growth. While Nexgel Inc ' s Revenue doubling of 108.39% ranks overall at the positon no. 249 in the second quarter 2023.




NXGL Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 108.39 % - - -
I Quarter March 55 % - - -
FY   - - - -

Financial Statements
Nexgel Inc 's second quarter 2023 Revenue $ 1.17 millions NXGL's Income Statement
Nexgel Inc 's second quarter 2022 Revenue $ 0.56 millions Quarterly NXGL's Income Statement
New: More NXGL's historic Revenue Growth >>


NXGL Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -8.77 % - -
III Quarter September - 1.79 % - -
II Quarter June 88.23 % 40 % - -
I Quarter March 19.23 % - - -
FY (Year on Year)   - - - -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #79
Overall #249

Revenue Y/Y Growth Statistics
High Average Low
108.02 % 82.29 % 56.57 %
(Jun 30 2023)   (Mar 31 2023)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #10
Healthcare Sector #79
Overall #249
Revenue Y/Y Growth Statistics
High Average Low
108.02 % 82.29 % 56.57 %
(Jun 30 2023)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nexgel Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
88.23 % 28.35 % -7.92 %
(Jun 30 2023)  


NXGL's II. Quarter Q/Q Revenue Comment
Nexgel Inc achieved in the II. Quarter 2023 above company average sequential Revenue jump of 88.23%, to $ 1.17 millions, from $0.62 millions in the first quarter.
Medical Equipment & Supplies company is undergoing a remarkable growth, not just reporting better then average increase, and also improving pace.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Nexgel Inc 's Revenue growth quarter on quarter, overall rank is 141.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #57
Overall #141
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #57
Overall #141
Revenue Q/Q Growth Statistics
High Average Low
88.23 % 28.35 % -7.92 %
(Jun 30 2023)  


NXGL's II. Quarter Q/Q Revenue Comment
Nexgel Inc achieved in the II. Quarter 2023 above company average sequential Revenue jump of 88.23%, to $ 1.17 millions, from $0.62 millions in the first quarter.
Medical Equipment & Supplies company is impressively improving, with reporting above regular gain, and also improving pace.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Nexgel Inc 's Revenue growth quarter on quarter, overall rank is 141.


Nexgel Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 2.88 $ 2.27 $ 2.05 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) 26.67 % 10.94 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1524 # 1924 # 0 # 0 # 0




Cumulative Revenue growth Comment
Nexgel Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 108.39% year on year, to $ 3 millions if the fiscal year would have ended in Jun 30 2023.
Nexgel Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2023. And, Nexgel Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But sequential growth rate was less at 26.67 % from $2.27 millions achieved in the period from Mar 31 2023 to Jun 30 2022.
Yet this was confirmation of positive momentum, while the usual sequential Revenue gain is at 0%.
The growth is even stronger from twelve months ended Mar 31 2023 clinched at 26.67 % rise from $2.27 millions in twelve months ending a quarter before.

Nexgel Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 270
S&P 500 # 1524
Cumulative Revenue growth Comment
Nexgel Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 108.39% year on year, to $ 3 millions if the fiscal year would have ended in Jun 30 2023.
Nexgel Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2023. And, Nexgel Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.
But from twelve months ended Mar 31 2023 increase was less at 26.67 % from $2.27 millions recorded in twelve months ending a quarter Mar 31 2023 Shanaya Yadav  continued.
In spite of, it was evidence of strength, while the typical sequential gain stands at 0%.
The growth was even higher from the previous reporting period exhibited at 26.67 % rise from $2.27 millions in twelve months ending a quarter before.

Nexgel Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 79
Sector # 270
S&P 500 # 1524




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NXGL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NXGL's Competitors
Revenue Growth for Nexgel Inc 's Suppliers
Revenue Growth for NXGL's Customers

You may also want to know
NXGL's Annual Growth Rates NXGL's Profitability Ratios NXGL's Asset Turnover Ratio NXGL's Dividend Growth
NXGL's Roe NXGL's Valuation Ratios NXGL's Financial Strength Ratios NXGL's Dividend Payout Ratio
NXGL's Roa NXGL's Inventory Turnover Ratio NXGL's Growth Rates NXGL's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Inmune Bio Inc 187.50%$ 187.500 millions
Anaptysbio inc184.54%$ 184.539 millions
2seventy Bio Inc 167.38%$ 167.379 millions
Clearside Biomedical Inc 165.10%$ 165.104 millions
Kiniksa Pharmaceuticals Ltd 164.99%$ 164.990 millions
Igc Pharma Inc 161.79%$ 161.792 millions
Bicycle Therapeutics Plc160.32%$ 160.324 millions
Mannkind Corporation157.28%$ 157.283 millions
Transmedics Group Inc 155.66%$ 155.665 millions
Mirati Therapeutics Inc 155.32%$ 155.315 millions
Tango Therapeutics Inc 152.95%$ 152.954 millions
Emmaus Life Sciences Inc 150.97%$ 150.968 millions
Mersana Therapeutics inc 148.69%$ 148.693 millions
Evoke Pharma Inc 144.99%$ 144.994 millions
Agile Therapeutics Inc144.40%$ 144.403 millions
Harpoon Therapeutics Inc 143.54%$ 143.538 millions
Chinook Therapeutics Inc 141.15%$ 141.148 millions
Ensysce Biosciences Inc 136.41%$ 136.405 millions
Novavax inc 128.28%$ 128.278 millions
Impel Pharmaceuticals Inc 127.04%$ 127.042 millions
Crinetics Pharmaceuticals Inc 125.06%$ 125.057 millions
Alkermes Plc 123.52%$ 123.517 millions
Invo Bioscience Inc 116.17%$ 116.171 millions
Comera Life Sciences Holdings Inc 114.72%$ 114.723 millions
Mirum Pharmaceuticals Inc 114.46%$ 114.465 millions
Arch Therapeutics Inc 112.31%$ 112.314 millions
Sintx Technologies Inc 111.67%$ 111.667 millions
Palatin Technologies Inc 109.04%$ 109.038 millions
Vbi Vaccines Inc108.09%$ 108.092 millions
Nexgel Inc 108.02%$ 108.021 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com